Navigation Links
Self-Retaining Bicanaliculus Intubation Set

ProductsSelf-Retaining Bicanaliculus Intubation Set
Company FCI Ophthalmics Inc.
Item Self-Retaining Bicanaliculus Intubation Set
Features 
Description Nicknamed the SRS, this new and innovative stent allows the physician to intubate the canaliculi in the office right at the chair with just topical anesthetic drops.

The SRS is made of medical grade silicone and is available in three lengths 25mm, 30mm and 35mm (disposable sizers sold separately). At each end of the stent is an anchor-shaped head to provide fixation. Each head consists of two flexible winglets that fold inwards during insertion through the punctum and spread back out after passage through the junction of the common canaliculus and lacrimal sac, thus securing the stent in place. A centrally placed marking on the tube acts as a reference point and allows verification of proper stent positioning following insertion. The winglets fold backwards for easy removal of the stent from the ducts.

Primary indications for the SRS include horizontal lacrimal duct stricture and punctal stenosis. Special consideration should be given to cancer patients on constricting drug therapies such as Taxotere.

Info FCI Ophthalmics Inc.Call FCI Ophthalmics Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-502-7279

Customer Service: 1-800-932-4202
Web site: http://www.fci-ophthalmics.com

Related medicine products :

1. TLC Self-Retaining Retractor System
2. Assistant Free™ Self-Retaining Hip Surgery Retractor System
3. Bika-Bicanaliculus Intubation
4. Crawford Bicanaliculus Intubation
5. Ritleng Bicanaliculus Intubation
6. Lacrimal Intubation Set, 23 gauge, 3/box
7. Lacrimal Intubation Set, 27 gauge, 3/box
8. Lacrimal Intubation Set, Olive Tip, 27 gauge, 3/box
9. BD Visitec Lacrimal Intubation and DCR Sets
10. Lacrimal Intubation Set
11. Lacrimal Intubation Tubing
...e immunoassay (EIA) kit for the in vitro detection... Cytoplasmic Antibodies (ANCA) directed against my...s of crescentic glomerulonephritis.,ANCA are ...tic disorders and glomerulonephritis (GN). They we...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase
... a polypeptide of 70 amino acids (7650 daltons), a...th factors present in the circulation. The molecul...roinsulin and has a number of biological activitie...e (GH) dependent to a high degree, but there is gr...
Genesis II Femoral Instrumentation
Medicine Products:
(Date:12/2/2008)...wire/ -- Research scientists using a,novel, hand-...have found that,chronic stroke patients can be re... at the annual meeting of the Radiological Society... using fMRI to map the brain in order to track,st...the brain has the ability to regain function throu...
(Date:12/2/2008)...e/ -- Today, the University HealthSystem,Consorti... been appointed Vice,President, Quality and Patie...,a year and a half as director of quality and infe...n Chicago, Ill. Previously, she was the senior di.... , "Julie,s experience at Northwestern has...
(Date:12/2/2008)...e-USNewswire/ -- A scientist who helped,explain h...s of information we,see has won the 2009 Univers.... , Anne Treisman, the James S. McDonnell Disti...rinceton University , was selected for the ninth G...ons. , Treisman, a cognitive psychologist, ...
(Date:12/2/2008)...ries have substantially higher rates of mental hea...g to results from a systematic review and meta-ana...Searching for studies over the past four decades c...rs in homeless people, Seena Fazel and colleagues ...involving 5,684 homeless individuals based in the ...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Julie Cerese Returns to University HealthSystem Consortium as Vice President of Quality and Patient Safety 2Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2
...registration of births by 2010 by amending the Reg...simplify the process, an official said Friday. 'R...lps in maintaining a record for a person for his o...the birth registration record is 64 percent as som...
... to sign an agreement that would reduce the cost o...try , an unnamed health ministry official announce...ficial did not specify how much Brazil would save ...ly will lower the cost of Abacavir from $2.76 per ...
... trouble times, if not exactly on the chopping bl...od and Drug Administration has said that the popul...ases it could be proving fatal. While the panel d...nges to the official instruction for the drug's us...
...as long as those who remain under a doctor's treat... Affairs researchers in a report published in the...available on line. "In an era when highly active ...man immunodeficiency virus that causes AIDS) is ke...
Other Medicine News:Health News:Government to Amend Birth Registration Act 2Health News:Anemia Drug Overused and Could Hasten Death in Some, Say Experts 2Health News:Anemia Drug Overused and Could Hasten Death in Some, Say Experts 3Health News:HIV Survival Improves If Patients Stay in Care 2
(Date:12/1/2008)... policy , , ROCHESTER, Minn., Dec. 1 /PRNe... finds the use of the drug therapy etanercept inef...inflammation of the liver caused by excessive cons...ublished in the December issue of Gastroenterolog...VIDEO ALERT: Additional audio and video resources,...
(Date:12/1/2008)...tCall/ -- Vical Incorporated (Nasdaq: VICL ) ann...ne payment from Merck & Co., Inc. based on Mer...l of an investigational plasmid DNA (pDNA) cancer ... DNA gene delivery technology and encodes human te...he subject of separate license agreement. , ,...
(Date:11/27/2008)...ute lymphoblastic leukemia relapse cases arise fro..., , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USN...arch Hospital have identified distinctive genetic ... lymphoblastic leukemia (ALL) that cause relapse. ...ts for ALL relapse in children and, ultimately, in...
(Date:11/25/2008)...re-USNewswire/ -- Kleinert Kutz and University of.... hand transplant on Messina, New York resident, J...l Hand Care Center on Monday, November 24. The in...eted shortly after 9 p.m. in a record nine hours. ...n/prnh/20081125/DC48555-a ) , (Photo: http://...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Hot peppers really do bring the heat 4362 1Despite Bad Economy Botox Sales Are Booming 25088 1Despite Bad Economy Botox Sales Are Booming 25088 2Lack of Time on Tummy Shown to Hinder Achievement of Developmental Milestones Say Physical Therapists 25084 1Lack of Time on Tummy Shown to Hinder Achievement of Developmental Milestones Say Physical Therapists 25084 2Lack of Time on Tummy Shown to Hinder Achievement of Developmental Milestones Say Physical Therapists 25084 3Lack of Time on Tummy Shown to Hinder Achievement of Developmental Milestones Say Physical Therapists 25084 4Exercise Lowers Risk of Colon Cancer 25081 1Exercise Lowers Risk of Colon Cancer 25081 2
..., Australia, May 03, 2007 /PRNewswire-FirstCall/ -... that the Company,intends to initiate a Phase 1b c...ty of the improved formulation of its transdermal,...cting insulin.,The trial is expected to commence i... is being developed as a novel "needle-free",way o...
...ER, N.J., May 03, 2007 /PRNewswire-FirstCall/ --,A...utical company,through its Pharmaceuticals Divisio...acokinetic study of its investigational,abuse-dete...scientific meeting of the American Pain Society in...e characteristics of this,extended-release morphin...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4